Abstracts Archive - Page 1671 of 2425 - ACR Meeting Abstracts

Abstract Number: 2986 • 2015 ACR/ARHP Annual Meeting
Systemic Sclerosis Patients on Intensive Care Unit – Reasons for Admission and Determinants of Outcome
Svetlana I. Nihtyanova¹, Francesco Figorilli², Christopher P. Denton³, Banwari Agarwal² and Voon H. Ong¹, ¹Rheumatology, UCL Division of Medicine, London, United Kingdom, ²ITU, Royal Free Hospital, London, United Kingdom, ³Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom
Background/Purpose: Little has been published on systemic sclerosis (SSc) patients requiring admission to Intensive Care Unit (ICU) for organ support; published results suggest respiratory failure…
Abstract Number: 2987 • 2015 ACR/ARHP Annual Meeting
An EULAR Study Group Pilot Study on Reliability of Simple� Capillaroscopic Definitions to Describe Capillary Morphology in Rheumatic Diseases
Vanessa Smith¹, Sam Beeckman², Ariane L. Herrick³, Saskia Decuman⁴, Ellen Deschepper⁵, Filip De Keyser⁶, Oliver Distler⁷, Ivan Foeldvari⁸, Francesca Ingegnoli⁹, Ulf Müller-Ladner¹⁰, Valeria Riccieri¹¹, Gabriela Riemekasten¹², Alberto Sulli¹³, Alexandre E. Voskuyl¹⁴ and Maurizio Cutolo¹³, ¹Department of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium, ²Department of Rheumatology, Ghent University, Ghent University Hospital,, Ghent, Belgium, ³Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, ⁴Department of Rheumatology, UGent, Ghent, Belgium, ⁵Biostatistics Unit, Biostatistics Unit, Ghent University, Ghent, Belgium, ⁶Rheumatology, Ghent University Hospital, Ghent, Belgium, ⁷Research of Systemic Autoimmune Diseases, Division of Rheumatology, University Hospital Zurich, 8952 Schlieren, Switzerland, ⁸Hamburger Zentrum für Kinder-und Jugendrheumatologie, Hamburg, Germany, ⁹Division of Rheumatology, Istituto Gaetano Pini, Department of Clinical Sciences & Community Health, University of Milano, Milano, Italy, ¹⁰Internal Medicine and Rheumatology, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, ¹¹Cattedra di Reumatologia, Dip Clinica e Terapia Medica, Sapienza Università di Roma, Roma, Italy, ¹²Clinic of Rheumatology, University of Luebeck, Lübeck, Germany, ¹³Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS A.O.U. San Martino-IST, University of Genova, Genoa, Italy, Genoa, Italy, ¹⁴Rheumatology, Amsterdam Rheumatology and immunology Center, location VU University medical center, Amsterdam, Netherlands
Background/Purpose: The EULAR study group on Microcirculation in Rheumatic Diseases (RD) aims to build an international network of centres of excellence to facilitate collaboration and…
Abstract Number: 2988 • 2015 ACR/ARHP Annual Meeting
Novel Use of Musculoskeletal Ultrasound (MSUS) to Measure Ulcers in the Skin of Systemic Sclerosis (SSc) Patients.
Yossra Suliman^1,2, Veena K. Ranganath², Suzanne Kafaja³ and Daniel E. Furst⁴, ¹Rheumatology and Rehabilitation department, Assiut university, Faculty of Medicine,, Assiut, Egypt, ²Medicine, Division of Rheumatology, David Geffen School of Medicine, Los Angeles, CA, ³Medicine/Rheumatology, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA, ⁴Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA
Background/Purpose: 1) To describe the role of MSUS, using both grey scale (GS) and Power Doppler (PD), to detect skin ulcers in SSc patients. 2)…
Abstract Number: 2989 • 2015 ACR/ARHP Annual Meeting
A Romanian Version of the University of Californa at Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT 2.0) Instrument
Marilena Gorga¹, Alina Soare¹, Rucsandra Dobrota¹, Ana Maria Gherghe¹, Victor Stoica² and Carina Mihai³, ¹Carol Davila University of Medicine and Pharmacy, Internal Medicine and Rheumatology, Cantacuzino Hospital, Bucharest, Romania, ²Internal Medicine and Rheumatology, Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, ³Internal Medicine and Rheumatology Departement, Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Background/Purpose: UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT 2.0) Instrument is a comprehensive, self-administered survey for the assessment of gastrointestinal involvement in patients…
Abstract Number: 2990 • 2015 ACR/ARHP Annual Meeting
Assessment of NT-Pro BNP As a Potential Marker for Pulmonary Hypertension in Systemic Sclerosis: Data from a Large, Prospective and Unselected Patient Cohort
Anna-Maria Hoffmann-Vold^1,2, Oyvind Midtvedt¹, Torhild Garen³, May Brit Lund⁴, Arne Andreassen⁵ and Øyvind Molberg⁶, ¹Rheumatology, Oslo University Hospital, Oslo, Norway, ²Institute of clinical medicine, University of Oslo, Oslo, Norway, ³Rheumatology, Department of Rheumatology, Oslo University Hospital, Oslo, Norway, ⁴Respiratory Diseases, Oslo University Hospital, Oslo, Norway, ⁵Cardiology, Oslo University Hospital, Oslo, Norway, ⁶Department of Rheumatology, Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway
Background/Purpose: In Systemic Sclerosis (SSc), pulmonary arterial hypertension (PAH) is often diagnosed at an advanced stage. Serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) are…
Abstract Number: 2991 • 2015 ACR/ARHP Annual Meeting
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis
Angela Chialà¹, Cinzia Rotondo¹, Maria Grazia Anelli¹, Emanuela Praino¹, Luca Cantarini², Crescenzio Scioscia¹, Margherita Giannini¹, Giovanni Lapadula¹ and Florenzo Iannone¹, ¹DIM, Rheumatology Unit, Bari, Italy, ²Univ Siena, Siena, Italy
Background/Purpose: Pericardial involvement is common in rheumatic disease, as rheumatoid arthritis, lupus erythematosus, mixed connective disease and systemic sclerosis. Few data are available about pathogenesis…
Abstract Number: 2992 • 2015 ACR/ARHP Annual Meeting
Identification of a New Set of Activity Criteria for Systemic Sclerosis. Preliminary Report
Gabriele Valentini¹, Michele Iudici², Veronika K. Jaeger³, Christopher P. Denton⁴, Oliver Distler⁵, Otylia M. Kowal-Bielecka⁶, Ulf Müller-Ladner⁷, Gabriela Riemekasten⁸, Ulrich A. Walker³, Suzana Jordan⁵, Elise Siegert⁸, Serena Vettori² and Yannick Allanore⁹, ¹Department of Clinical and Experimental Medicine, Rheumatology Unit, Rheumatology Unit, Second University of Naples, Naples, Italy, ²Department of Internal and Experimental Medicine, Rheumatology Unit, Second University of Naples, Naples, Italy, ³Department of Rheumatology, University Hospital Basel, Basel, Switzerland, ⁴Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, ⁵Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, ⁶Department of Rheumatology and Internal Medicine, Medical University in Bialystok, Bialystok, Poland, ⁷Internal Medicine and Rheumatology, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, ⁸Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Berlin, Germany, ⁹Department of Rheumatology, University Paris Descartes and Cochin Hospital, Paris, France
Background/Purpose: The European Scleroderma Study Group (EScSG) Activity Index developed in 2001 has some limitations due to the procedure underlying its development and the inclusion…
Abstract Number: 2993 • 2015 ACR/ARHP Annual Meeting
Serum CXCL4 Increase in Patients with Undifferentiated Connective Tissue Disease at Risk for Systemic Sclerosis Is Associated with Anti-Scl70 Antibodies and ICAM-1, a Marker of Endothelial Activation
Serena Vettori¹, Rosaria Irace², Veronica Giacco², Antonella Riccardi², Lucia Vicedomini², Luciana Pellecchia² and Gabriele Valentini², ¹Department of Internal and Experimental Medicine, Rheumatology Unit, Second University of Naples, Naples, Italy, ²Internal and Experimental Medicine, Rheumatology Unit, Second University of Naples, Naples, Italy
Background/Purpose: CXCL4 is a pleiotropic antiangiogenic and immunomodulatory chemokine, that has been shown to be increased in the sera of patients with systemic sclerosis (SSc)…
Abstract Number: 2994 • 2015 ACR/ARHP Annual Meeting
The Global Microrna Profile of Systemic Sclerosis Whole Skin/Dermal Fibroblasts and the Role of the Xq26.3 miRNA Cluster As a TGF-b Pathway Positive Feedback Mechanism
Gloria Salazar¹, John Hagan², Minghua Wu³, Xinjian Guo⁴, Xiaodong Zhou⁴, Julio Charles¹, Maureen D Mayes¹ and Shervin Assassi¹, ¹Rheumatology, University of Texas Medical School at Houston, Houston, TX, ²Neurosurgery, University of Texas at Houston, Houston, TX, ³Feinberg School of Medicine, Northwestern University, Chicago, IL, ⁴Internal Medicine, University of Texas Medical School at Houston, Houston, TX
Background/Purpose: MicroRNA (miRNA) are critical gene regulators that frequently play central roles in disease. Here, we report the miRNA expression signatures of systemic sclerosis (SSc)…
Abstract Number: 2995 • 2015 ACR/ARHP Annual Meeting
Genome Wide Analysis in Scleroderma Renal Crisis: Defining Genetic Risk in Patients with RNA Polymerase III Auto-Antibodies
Maria C Fonseca¹, Sandra Guerra¹, Edward Stern^1,2, Svetlana I. Nihtyanova¹, David Abraham³, Aine Burns², Mark Harber² and Christopher P. Denton⁴, ¹Rheumatology, UCL Division of Medicine, London, United Kingdom, ²Nephrology, Royal Free Hospital, London, United Kingdom, ³Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, ⁴Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom
Background/Purpose: Scleroderma renal crisis (SRC) is a severe complication of systemic sclerosis (SSc). Most SSc cases demonstrate a disease-specific antinuclear antibody including anti-RNA polymerase III…
Abstract Number: 2996 • 2015 ACR/ARHP Annual Meeting
Evaluation of Systemic Sclerosis Risk Genes in the Turkish Population
Javier Martín¹, Francisco David Carmona², Tamara Fernández-Aranguren¹, Alberto Serrano-Fernández³, Ahmet Mesut Onat⁴, Gema Robledo⁵, Enrique Raya⁶, Haner Direskeneli⁷, Amr H. Sawalha⁸ and Sule Yavuz⁹, ¹Instituto de Parasitología y Biomedicina López- Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain, ²Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain, ³Immunology, Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, Armilla, Spain, ⁴Ä°nternal Medicine Division of Rheumatology, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey, ⁵Immunology, Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, Granada, Spain, ⁶Rheumatology, Hospital Clínico San Cecilio, Granada, Spain, ⁷Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, ⁸Division of Rheumatology, University of Michigan, Ann Arbor, MI, ⁹Rheumatology, Istanbul Bilim University, Faculty of Medicine,Department of Rheumatology, Istanbul, Turkey
Background/Purpose: The use of high-throughput genotyping platforms has allowed a better understanding of the genetic background underlying systemic sclerosis (SSc). Sixteen non-HLA genes have been…
Abstract Number: 2997 • 2015 ACR/ARHP Annual Meeting
A Genome-Wide Association Study of a Hispanic Systemic Sclerosis Cohort
Lara Bossini-Castillo¹, Enrique Raya², John D. Reveille³, Shervin Assassi⁴, Olga Y Gorlova⁵, Dinesh Khanna⁶, Daniel E. Furst⁷, Suzanne Kafaja⁸, Robert W. Simms⁹, Robert Lafyatis⁹, Tracy M. Frech¹⁰, Virginia D. Steen¹¹, Barri J. Fessler¹², Jerry A. Molitor¹³, Marta Alarcón-Riquelme^14,15, Javier Martín¹⁶ and Maureen D Mayes⁴, ¹Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS Granada, Granada, Spain, ²Rheumatology, Hospital Clínico San Cecilio, Granada, Spain, ³Internal Medicine/Rheumatology, University of Texas Medical School at Houston, Houston, TX, ⁴Rheumatology, University of Texas Medical School at Houston, Houston, TX, ⁵Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH, ⁶Division of Rheumatology, University of Michigan, Ann Arbor, MI, ⁷Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, ⁸Rheumatology, University of California Los Angeles, Los Angeles, CA, ⁹Rheumatology, Boston University School of Medicine, Boston, MA, ¹⁰Div of Rheumatology, University of Utah, Salt Lake City, UT, ¹¹Department of Rheumatology, Georgetown University Medical Center, Washington, DC, ¹²Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, ¹³Rheumatology, University of Minnesota, Minneapolis, MN, ¹⁴Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma, OK, ¹⁵Centre for Genomics and Oncological Research (GENYO), Pfizer–University of Granada–Junta de Andalucia, Parque Tecnológico de la Salud (PTS), Granada, Spain, ¹⁶Instituto de Parasitología y Biomedicina López- Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain
Background/Purpose: Genome-wide association studies (GWASs) have resulted in the identification of several genetic loci involved in systemic sclerosis (SSc) susceptibility. However, GWASs are normally focused…
Abstract Number: 2998 • 2015 ACR/ARHP Annual Meeting
Microchimerism Is Present in Systemic Sclerosis Lung and Includes CD31-Positive Cells
Coline GENTIL¹, Julie Randolph-Habecker², David. K. Madtes^3,4, Min FANG⁵, Hilary S. Gammill⁶, Corinne L. Fligner⁷, McGarry, A. Houghton^3,8 and J. Lee Nelson^9,10, ¹Clinical Division, Fred Hutchinson Cancer Research Center, SEATTLE, WA, ²Histopathology, Fred Hutchinson Cancer Research Center, SEATTLE, WA, ³Clinical Research, Fred Hutchinson Cancer Research Center, SEATTLE, WA, ⁴University of Washington, SEATTLE, WA, ⁵Cytogenetics, Seattle Cancer Care Alliance, SEATTLE, WA, ⁶Obstetrics and Gynecology, University of Washington, Seattle, WA, ⁷Pathology, University of Washington, SEATTLE, WA, ⁸Pulmonary medicine, University of Washington, SEATTLE, WA, ⁹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, ¹⁰University of Washington, Seattle, WA
Background/Purpose: Microchimerism (Mc), harboring a small number of cells (or DNA) that originated in a different individual, occurs commonly due to bi-directional maternal-fetal exchange during…
Abstract Number: 2999 • 2015 ACR/ARHP Annual Meeting
Maternal Microchimerism Is Increased in Multiple Cellular Subsets of Patients with Systemic Sclerosis Compared to Healthy Controls
Sami B. Kanaan¹, Whitney Harrington^2,3, Laurence S. Loubiere⁴, Tessa M. Aydelotte¹ and J. Lee Nelson^1,5, ¹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, ²Seattle Children's Hospital, Seattle, WA, ³Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, ⁴University of Birmingham, Birmingham, United Kingdom, ⁵University of Washington, Seattle, WA
Background/Purpose: Microchimerism (Mc) is naturally acquired through bi-directional exchange of small amounts of cells or DNA between mother and fetus during pregnancy. Higher amounts of…
Abstract Number: 3000 • 2015 ACR/ARHP Annual Meeting
Intrinsic Gene Expression Subset Predicts Improvement in Systemic Sclerosis Patients during Dasatinib (SprycelTM) Therapy
Viktor Martyanov¹, Jonathan Goldin², Kim Hyun³, Oumar Sy⁴, Wendy Hayes⁴, Shuyan Du⁴, Michael Whitfield¹ and John Varga⁵, ¹Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH, ²David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, ³Radiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, ⁴Bristol-Myers Squibb, Princeton, NJ, ⁵Division of Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL
Background/Purpose: Intrinsic gene expression subsets are molecular pathway-driven subtypes of systemic sclerosis (SSc) that have been reproduced across multiple cohorts of SSc patients. The goal…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].